John Sherrill Email

Senior Scientist . Cedilla Therapeutics

Current Roles

Employees:
9
Revenue:
$697.5k
About
Cedilla Therapeutics is discovering and exploiting unique insights into protein stability. Cedilla’s integrated, multi-faceted approach has the potential to broaden the reach of small molecules by generating therapeutics that degrade protein targets as their primary mechanism of action. The approach harnesses intrinsic degradation pathways that are upstream of ubiquitination. Cedilla is focused on destabilizing oncoprotein targets using a product engine that is also applicable to targets outside of oncology. Cedilla was launched in 2018 by Third Rock Ventures and is based in Cambridge, Mass. For more information, please visit www.cedillatx.com.
Cedilla Therapeutics Address
245 First Street
Cambridge, MA
United States
Cedilla Therapeutics Email

Past Companies

Aleksia TherapeuticsSenior Research Scientist
Cedilla TherapeuticsSenior Scientist
Cedilla TherapeuticsScientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.